Biodelivery sciences announces $25 million share repurchase program

Raleigh, n.c., nov. 04, 2020 (globe newswire) -- biodelivery sciences international, inc. (nasdaq: bdsi), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that its board of directors has authorized the repurchase of up to $25 million of the company's shares of common stock.

BDSI Ratings Summary

BDSI Quant Ranking